EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles

BACKGROUND: The EIF1AX mutation has been identified in various benign and malignant thyroid lesions, with a higher prevalence in poorly differentiated thyroid carcinoma (PDTC) and anaplastic thyroid carcinoma, especially when combined with RAS or TP53 mutation. However, data and clinical significanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsherbini, Noha, Kim, Dong Hyun, Payne, Richard J., Hudson, Thomas, Forest, Véronique-Isabelle, Hier, Michael P., Payne, Alexandra E., Pusztaszeri, Marc P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652817/
https://www.ncbi.nlm.nih.gov/pubmed/36371345
http://dx.doi.org/10.1186/s40463-022-00594-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652817/
https://www.ncbi.nlm.nih.gov/pubmed/36371345
http://dx.doi.org/10.1186/s40463-022-00594-6

Ejemplares similares